Severe Cutaneous Adverse Reaction Caused by Carbamazepine and Levofloxacin After Varicella Zoster Virus Infection

References

• Zhang J, Lei Z, Xu C, Zhao J, Kang X. Current perspectives on severe drug eruption. Clin Rev Allergy Immunol. 2021;61(3):282–298. doi:10.1007/s12016-021-08859-0
   PubMed Web of Science ®Google Scholar
• Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331:1272–1285. doi:10.1056/NEJM199411103311906
   PubMed Web of Science ®Google Scholar
• Zheng L, Jin H-B, Guan Y-Y, Yang J. Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients. BMC Pharmacol Toxicol. 2022;23:62. doi:10.1186/s40360-022-00603-4
   PubMed Web of Science ®Google Scholar
• Szatkowski J, Schwartz RA. Acute generalized exanthematous pustulosis (AGEP): a review and update. J Am Acad Dermatol. 2015;73(5):843–848. doi:10.1016/j.jaad.2015.07.017
   PubMed Web of Science ®Google Scholar
• Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017;390(10106):1996–2011. doi:10.1016/S0140-6736(16)30378-6
   PubMed Web of Science ®Google Scholar
• Kim TI, Jeong KH, Shin MK, Kim NI. Piperacillin/Tazobactam-Associated Hypersensitivity Syndrome with Overlapping Features of Acute Generalized Exanthematous Pustulosis and Drug-Related Rash with Eosinophilia and Systemic Symptoms Syndrome. Ann Dermatol. 2016;28(1):98–101. doi:10.5021/ad.2016.28.1.98
   PubMed Web of Science ®Google Scholar
• Totonchy MB. Koebnerization of Hailey-Hailey disease into a cutaneous drug eruption of acute generalized exanthematous pustulosis associated with systemic symptoms. Case Reports, J Cutan Pathol. 2016;43(11):1031–1035. doi:10.1111/cup.12771
   PubMed Web of Science ®Google Scholar
• Ikeda T, Yokoyama K, Kawakami T. Overlapping acute generalized exanthematous pustulosis drug reaction with eosinophilia and systemic symptoms induced by a second dose of the Moderna COVID- 19 vaccine. J Dermatol. 2022;49(12):e446–e447. doi:10.1111/1346-8138.16541
   PubMed Web of Science ®Google Scholar
• Tay WC, Lee JSS, Chong WS. Tozinameran (Pfizer-BioNTech COVID-19 vaccine)-induced AGEP-DRESS syndrome.Ann. Acad Med Singap. 2022;51(12):796–797. doi:10.47102/annals-acadmedsg.2022338
   PubMed Web of Science ®Google Scholar
• Gey A, Milpied B, Dutriaux C, et al. cutaneous adverse reaction associated with vemurafenib: DRESS, AGEP or overlap reaction? J Eur Acad Dermatol Venereol. 2016;30(1):178–179. doi:10.1111/jdv.12685
   PubMed Web of Science ®Google Scholar
• Tedbirt B, Viart-Commin M-H, Carvalho P, Courville P, Florence T. Severe acute generalized exanthematous pustulosis (AGEP) induced by miconazole oral gel with overlapping features of drug reaction with eosinophilia and systemic symptoms (DRESS). Contact Dermatitis. 2021;84(6):474–476. doi:10.1111/cod.13773
   PubMed Web of Science ®Google Scholar
• Perelló MI, de Maria Castro A, Nogueira Arraes AC. Severe cutaneous adverse drug reactions: diagnostic approach and genetic study in a Brazilian case series. Eur Ann Allergy Clin Immunol. 2022;54(5):207–217. doi:10.23822/EurAnnACI.1764-1489.193
   PubMedGoogle Scholar
• Bouvresse S, Valeyrie-Allanore L, Ortonne N, et al. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? Orphanet J Rare Dis. 2012;25(7):72. doi:10.1186/1750-1172-7-72
   Google Scholar
• Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156:1083–1084. doi:10.1111/j.1365-2133.2007.07807.x
   PubMed Web of Science ®Google Scholar
• Sussman M, Napodano A, Huang S, Are A, Hsu S, Motaparthi K. Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis. Medicina. 2021;57(10):1004. doi:10.3390/medicina57101004
   PubMedGoogle Scholar
• Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol. 2021;77(3):275–289. doi:10.1007/s00228-020-03005-9
   PubMed Web of Science ®Google Scholar
• Stirton H, Shear NH, Dodiuk-Gad RP. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)—Readdressing the DReSS. Biomedicines. 2022;10(5):999. doi:10.3390/biomedicines10050999
   PubMed Web of Science ®Google Scholar
• Miyagawa F, Asada H. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).Int. J Mol Sci. 2021;22(4):2147. doi:10.3390/ijms22042147
   Google Scholar
• Wang C-W. An Updated Review of Genetic Associations With Severe Adverse Drug Reactions: translation and Implementation of Pharmacogenomic Testing in Clinical Practice. Front Pharmacol. 2022;13:886377. doi:10.3389/fphar.2022.886377
   PubMed Web of Science ®Google Scholar
• Cardones AR. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Clin Dermatol. 2020;38(6):702–711. doi:10.1016/j.clindermatol.2020.06.008
   PubMed Web of Science ®Google Scholar
• Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S. Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol. 2021;77(3):275–289.
   PubMed Web of Science ®Google Scholar
• Schunkert EM, Divito SJ. Updates and Insights in the Diagnosis and Management of DRESS Syndrome. Curr Dermatol Rep. 2021;10(4):192–204. doi:10.1007/s13671-021-00348-z
   PubMed Web of Science ®Google Scholar
• Mockenhaupt M. Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. J Dtsch Dermatol Ges. 2009;7(2):142–160. doi:10.1111/j.1610-0387.2008.06878.x
   PubMed Web of Science ®Google Scholar